Surge in Open Interest Signals Increased Market Activity for Sun Pharmaceutical
Sun Pharmaceutical Industries Ltd has seen a notable rise in open interest, reaching 108,281 contracts, alongside a trading volume of 44,795 contracts, indicating increased market activity. Despite a slight underperformance today, the stock has shown positive movement over the past week and maintains a strong market capitalization within its sector.
Sun Pharmaceutical Industries Ltd (symbol: SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in its futures market. The latest open interest stands at 108,281 contracts, up from the previous figure of 94,807, marking a change of 13,474 contracts or a 14.21% increase. This surge in open interest coincides with a trading volume of 44,795 contracts, indicating robust market engagement.In terms of price performance, Sun Pharmaceutical has underperformed its sector by 0.37% today, although it has shown a positive trend over the past five days, gaining 1.94%. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, but remains below its 200-day moving average. Notably, the delivery volume on July 28 reached 14.49 lakh shares, reflecting a 57.1% increase compared to the 5-day average, suggesting rising investor participation.
With a market capitalization of Rs 4,10,382.25 crore, Sun Pharmaceutical continues to maintain a solid position within the Pharmaceuticals & Biotechnology industry. The increase in open interest and trading volume highlights the stock's active engagement in the market, underscoring the current dynamics at play.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
